Drug delivery-the increasing momentum
Drug delivery and the drug modalities in the discovery and development pipelines of the Pharmaceutical and Biotechnology Industries have changed significantly over the last 25 years. Drug delivery was traditionally used primarily to enhance oral exposure or prolong exposure of small molecules and the early peptide drugs. The world is rapidly changing; the drug modalities are diversifying, and drug delivery scientists must play a more prominent role and are core to the genesis of innovative medicines of the future. This note shows where delivery science can play a critical role in treating diseases of the future. It outlines some of the skills, capabilities and behaviours that will be critical for the success of the next generation of medicines and illustrates where drug delivery science will be required at the inception of projects in discovery as well as in development where until recently this has predominantly been the case. Finally, it asks whether we are ready for this evolution.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Drug delivery and translational research - 10(2020), 6 vom: 06. Dez., Seite 1888-1894 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ashford, Marianne [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Delivery Science |
|---|
| Anmerkungen: |
Date Completed 01.11.2021 Date Revised 01.11.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s13346-020-00858-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM31595714X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM31595714X | ||
| 003 | DE-627 | ||
| 005 | 20231225160034.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s13346-020-00858-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1053.xml |
| 035 | |a (DE-627)NLM31595714X | ||
| 035 | |a (NLM)33025537 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ashford, Marianne |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Drug delivery-the increasing momentum |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.11.2021 | ||
| 500 | |a Date Revised 01.11.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Drug delivery and the drug modalities in the discovery and development pipelines of the Pharmaceutical and Biotechnology Industries have changed significantly over the last 25 years. Drug delivery was traditionally used primarily to enhance oral exposure or prolong exposure of small molecules and the early peptide drugs. The world is rapidly changing; the drug modalities are diversifying, and drug delivery scientists must play a more prominent role and are core to the genesis of innovative medicines of the future. This note shows where delivery science can play a critical role in treating diseases of the future. It outlines some of the skills, capabilities and behaviours that will be critical for the success of the next generation of medicines and illustrates where drug delivery science will be required at the inception of projects in discovery as well as in development where until recently this has predominantly been the case. Finally, it asks whether we are ready for this evolution | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Delivery Science | |
| 650 | 4 | |a Drug Delivery | |
| 650 | 4 | |a Future medicines | |
| 650 | 4 | |a Pharmaceutical Research and Development | |
| 650 | 7 | |a Pharmaceutical Preparations |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Drug delivery and translational research |d 2011 |g 10(2020), 6 vom: 06. Dez., Seite 1888-1894 |w (DE-627)NLM207177104 |x 2190-3948 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2020 |g number:6 |g day:06 |g month:12 |g pages:1888-1894 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s13346-020-00858-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2020 |e 6 |b 06 |c 12 |h 1888-1894 | ||